Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

C

Chinese PLA General Hospital

Academic

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

48

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

A Therapeutic Effect Evaluation System for Multifidus Muscle Injury in the Lumbar Region Was Constructed Based on Ultrasound Radiomics

A Phase I/II Clinical Study Evaluating the Safety and Efficacy of BEX101 in Patients With Relapsed/Refractory B-Cell Lymphoma

Prevalence and Risk Factors for Postoperative Anxiety and Depression Symptoms in Non-cardiac Surgery Among Chinese Elderly Patients

Earlier

Oct 22, 2026TrialThe Comparison of Different Cycles of PD-1 Blockades Combined With Chemotherapy as Neoadjuvant Therapy for Patients With Advanced Gastric Cancer

Oct 17, 2026TrialEffect of Ultrasound-Guided Serratus Anterior Plane Block on Postoperative Recovery Quality in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting: A Single-Center, Randomized, Double-Blind Controlled Trial

Oct 16, 2026TrialUsing Single-cell Sequencing to Explore Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy

Oct 6, 2026TrialEfficacy and Safety of Low-Intensity Focused Ultrasound Targeting the Dorsolateral Prefrontal Cortex for Preventive Treatment of Chronic Migraine in Adults: A Randomized, Single-Blind, Sham-Controlled Trial

Sep 18, 2026TrialCombination Therapy of Microwave Ablation and Expanding Activated Autologous Lymphocytes for Hepatocellular Carcinoma

3 more events

Sep 18, 2026TrialChina Cochlear Implant for 30 Years: Epidemiology, Policy Effects and Health Economics Evaluation of Cochlear Implantation in China

Sep 17, 2026TrialA Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Manganese-primed Immunochemotherapy in Subjects With Advanced Ovarian Cancer

Sep 16, 2026TrialObinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis: A Prospective Exploratory Study

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)